Layout table for study information Study Type Interventional Clinical Trial Actual Enrollment 260 participants Allocation Randomized Intervention Model Crossover Assignment Masking None Open Label Primary Purpose Treatment Official Title A Randomized Phase II III Study to Assess the Efficacy of Trametinib GSK 1120212 in Patients With Recurrent or Progressive Low Grade Serous Ovarian Cancer or Peritoneal Cancer Actual Study Start Date April 11, 2014 Actual Primary Completion Date April 4, 2019 <a href=
https://dapoxetine.buzz>priligy tablets online</a> However, average serum creatinine during the observed week was higher in PAL treated patients 1